adminEuropean Stocks Decline on Weak US Jobs Data; Novo Nordisk Falls
European stocks fell as sentiment took a hit from weak US jobs data, with investors also tracking a busy slate of earnings and key interest-rate decisions. Novo Nordisk A/S dropped…
Eli Lilly gaining in GLP-1 market over Novo Nordisk, earnings show
The Eli Lilly and Novo Nordisk logos. Mike Blake | Tom Little | Reuters It’s a tale of two drugmakers in the red-hot obesity drug market. Both Novo Nordisk and…
Next steps for Eli Lilly, Novo Nordisk, Pfizer
A pharmacist displays a box of Wegovy pills at a pharmacy in Provo, Utah, Jan. 15, 2026. George Frey | Bloomberg | Getty Images The future of the booming obesity…
Novo Nordisk, Pfizer execs weigh in
President Donald Trump arrives for an announcement in the Roosevelt Room of the White House in Washington, Dec. 19, 2025. Will Oliver | Bloomberg | Getty Images Drug pricing. Looming…
Novo Nordisk shares rise after Wegovy obesity pill launch
A pharmacist displays a box of Wegovy pills at a pharmacy in Provo, Utah, Jan. 15, 2026. George Frey | Bloomberg | Getty Images Shares of Novo Nordisk rose more…
Amazon Pharmacy starts offering Novo Nordisk’s Wegovy weight loss pill
Close-up of a hand holding a cellphone displaying the Amazon Pharmacy system, Lafayette, California, Sept. 15, 2021. Smith Collection | Gado | Getty Images Amazon announced Friday it now offers…
2026 is the year of obesity pills from Novo Nordisk, Eli Lilly
The booming GLP-1 space was built on weekly injections. In 2026, new obesity pills will push the market into its next chapter. Patients are already getting their hands on the…
FDA approves first GLP-1 pill for obesity from Wegovy maker Novo Nordisk
The U.S. Food and Drug Administration on Monday approved the first-ever GLP-1 pill for obesity from Wegovy maker Novo Nordiska landmark decision that health experts say could open up treatment…
Novo Nordisk cuts cash prices for Wegovy, Ozempic
Boxes of Ozempic and Wegovy made by Novo Nordisk at a pharmacy in London on March 8, 2024. Hollie Adams | Reuters Novo Nordisk on Monday said it has cut…
Trump deals with Lilly, Novo Nordisk could broaden obesity drug access
US President Donald Trump makes an announcement in the Oval Office of the White House in Washington, DC on Nov. 6, 2025. Andrew Caballero-Reynolds | AFP | Getty Images President…
